Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P2AB
|
|||
| Drug Name |
Azole derivative 3
|
|||
| Synonyms |
PMID26413912-Compound-66
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
MERCK SHARP & DOHME CORP. YANG, ZhiQiang NANTERMET, Philippe, G. KREATSOULAS, Constantine MOORE, Keith, P. SHALEN, Evan Foster
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.